Observational studyBMJ open2025

Participants' perspectives of the advanced ovarian cancer biomarker study VALTIVE1: a qualitative study.

Daniella Holland-Hart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.